Substance Use Trends Across Canadian Jurisdictions, 2008–2024:
The Prevalence Interactive Chart
Logarithmic scale used for readability
Substances Covered
This tool includes data on the following substance categories:
- Alcohol (former alcohol use, alcohol use, mean drinks per week)
- Tobacco (former tobacco use, tobacco use)
- Cannabis
- Opioids
- Other CNS depressants
- Cocaine
- Other CNS stimulants
- Any other psychoactive substances (including hallucinogens and inhalants)
Explore the Data
Interpret the 2024 estimates with caution as they are based on linear extrapolation methods using data from 2014 to 2023 and they may not reflect actual observed values.
Exposure estimates can be broken out by:
- Province or territory
- Year (2008-2024)
- Sex
- Age group (15-34, 35-64, and 65+)
Three primary metrics are available:
- Prevalence (percentage of people using a substance)
- Counts (number of users)
- Standard drinks (SDs) per week (For alcohol only; this indicator shows the magnitude of alcohol consumption. One Canadian standard drink=13.45 grams of ethanol or 17.05 ml. There are three metrics based on self-reported, sales-based and total alcohol intake per person.)
Trends and Prevalence: How Estimates Were Developed
To produce new and reliable prevalence estimates of substance use trends across Canada, we combined self-reported survey data from national and regional health surveys (refer to the table), including individuals who reported having used a given substance for different frequencies within the past 12 months, regardless of whether the use was medical or non-medical (with broader criteria for some substances, including alcohol and tobacco; refer to the glossary for details). For more information about the methodology, please contact the CSUCH team.
For alcohol, the most used substance, we were able to estimate the average number of drinks consumed per day and the prevalence of binge drinking. For both alcohol and tobacco, we also estimated the percentage of the population who reported using these substances during their lifetime but not in the past 12 months.
Despite these surveys offering valuable information, they often have limitations such as missing years, underrepresented subgroups or suppressed data for smaller provinces or age groups.
To counter these limitations and produce statistically reliable estimates with reduced variance and broader coverage, we used a statistical modelling approach that incorporates:
-
Self-reported prevalence data from surveys like the:
- Canadian Alcohol and Drug Use Monitoring Survey (CADUMS) (Health Canada, 2013),
- Canadian Tobacco, Alcohol and Drugs Survey (CTADS) (Health Canada, 2018),
- Canadian Alcohol and Drugs Survey (CADS) (Statistics Canada, 2021),
- Canadian Substance Use Survey (CSUS) (Health Canada, 2025),
- Canadian Tobacco and Nicotine Survey (CTNS) (Health Canada, 2023),
- Canadian Cannabis Survey (CCS) (Health Canada, 2024a), and
- Canadian Community Health Survey (CCHS) (Statistics Canada, 2023).
- Northwest Territories Substance Use and Addictions Survey 2018, 2023 (Northwest Territories Health and Social Services, 2024).
- Sales data for alcohol and tobacco to support estimates, where self-reporting may underestimate use (Statistics Canada, 2025a; Statistics Canada, 2025b).
- Hospitalization and health administrative records from the Canadian Institute for Health Information (CIHI, 2025), including inpatient hospitalizations whoSlly attributable to alcohol and other drugs.
- Police seizure data from Health Canada’s Drug Analysis Service (DAS) (Statistics Canada, 2024b).
- Demographic and income data by jurisdiction and year (Statistics Canada, 2025c).
For example, to estimate cocaine use among men aged 35–64 in Ontario in 2020, we modelled survey data from surrounding years and regions alongside hospitalization and drug seizure records. This enabled us to fill data gaps and reduce uncertainty while collecting broader national trends over time.
| Substance | Data Sources |
|---|---|
| Alcohol |
|
| Tobacco |
|
| Cannabis |
|
| Opioids, other CNS depressants, cocaine, other CNS stimulants and other substances |
|
Glossary
| Term | Definition |
|---|---|
| Alcohol | |
| Former Alcohol Use | Consumed at least one alcohol drink in their lifetime but not in the past 12 months |
| Alcohol Use | Consumed alcohol drinks in the past 12 months |
| Sales-Based Alcohol Intake Per Person | Alcohol consumed per person based on per capita sales data from Statistic Canada, expressed in SDs per week |
| Total Alcohol Intake Per Person | Sales-based alcohol intake adjusted for unrecorded alcohol consumption using World Health Organization estimates, expressed in SD per week. |
| Tobacco | |
| Former tobacco use | Smoked at least 100 cigarettes in their lifetime but did not smoke daily or occasionally |
| Tobacco use | Smoked daily or occasionally in the past 12 months |
| Cannabis | |
| Cannabis Use | Use of cannabis (which refers to marijuana and related products made from the cannabis plant) in the past 12 months, including for medical purposes |
| Opioids | |
| Opioids Use | Use of heroin and prescription opioid pain relivers such as oxycodone, hydromorphone and morphine in the past 12 months, excluding opioid replacement therapies and non-opioid analgesics |
| Other CNS depressants | |
| Other CNS Depressants Use | Use of any sedating or tranquillizing products like Valium, Ativan and Xanax in the past 12 months |
| Cocaine | |
| Cocaine Use | Use of cocaine or crack (freebase, powder, snow) in the past 12 months |
| Other CNS stimulants | |
| Other CNS Stimulants Use | Use of amphetamines (e.g., methamphetamines, MDMA) and prescription stimulants like Ritalin and Adderall in the past 12 months |
| Other substances | |
| Other psychoactive substances use | Use of hallucinogens (e.g., LSD, psilocybin), inhalants (e.g., glue, gasoline) and any other substances used to get high in the past 12 months |
| Metric | |
| Prevalence | Estimated percentage of individuals who reported using a substance within each demographic group across a defined period |
| Count | Estimates number of individuals using a substance within each demographic group |
| Standard drink (SD) | One SD = 13.45 (6) g or 17.05 ml of ethanol in Canada |
Canadian Substance Use Costs and Harms Scientific Working Group. (2023). Canadian substance use costs and harms (2007–2020). Ottawa, Ont.: Canadian Centre on Substance Use and Addiction.
Show References
-
Canadian Institute for Health Information. (2025). Discharge abstract database (DAD) metadata, 2006/07 to 2023/2024 [Data file]. Ottawa, Ont.: Author.
Retrieved from: https://www.cihi.ca/en/discharge-abstract-database-dad-metadata
-
Health Canada. (2013). Canadian alcohol and drug use monitoring survey: summary of results for 2012 [Data file]. Ottawa, Ont.: Author.
Retrieved from: https://www.canada.ca/en/health-canada/services/canadian-alcohol-drugs-survey/canadian-alcohol-drug-use-monitoring-survey-summary-results-2012.html
-
Health Canada. (2018). Canadian tobacco, alcohol and drugs survey (CTADS): summary of results for 2017 [Data file]. Ottawa, Ont.: Author.
Retrieved from: https://www.canada.ca/en/health-canada/services/canadian-alcohol-drugs-survey/2017-summary.html
-
Health Canada. (2023). Canadian tobacco and nicotine survey (CTNS): summary of results for 2022 [Data file]. Ottawa, Ont.: Author.
Retrieved from: https://www.canada.ca/en/health-canada/services/canadian-tobacco-nicotine-survey/2022-summary.html
-
Health Canada. (2024a). Canadian cannabis survey 2023: summary [Custom data request]. Ottawa, Ont.: Author.
Retrieved from: https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2023-summary.html
-
Health Canada. (2024b). Drug analysis service and cannabis laboratory. Ottawa, Ont.: Author.
Retrieved from: https://health-infobase.canada.ca/drug-analysis-service/analyzed-drug-report.html?p=BC&y=2023&q=all&r=DASreport
-
Health Canada. (2025). Canadian substance use survey: summary of results 2023 [Custom data request]. Ottawa, Ont.: Author.
Retrieved from: https://www.canada.ca/en/health-canada/services/canadian-alcohol-drugs-survey/2023-summary.html
-
Health Canada. (2025b). Tobacco sales: reported sales of tobacco products by manufacturers and importers in Canada, 2001 to 2024. Ottawa, Ont.: Author.
Retrieved from: https://health-infobase.canada.ca/substance-use/tobacco/sales/
-
Northwest Territories Health and Social Services. (2024). Northwest Territories substance use and addictions survey: 2018 and 2023. Yellowknife, N.W.T.: Author.
Retrieved from: https://www.statsnwt.ca/recent_surveys/
-
Statistics Canada. (2021). Canadian alcohol and drugs survey (CADS) [Data file]. Ottawa, Ont.: Author.
Retrieved from: https://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=5289
-
Statistics Canada. (2023). Canadian Community Health Survey (CCHS) — 2008 [Data file]. Ottawa, Ont.: Author.
Retrieved from: https://www23.statcan.gc.ca/imdb/p3Instr.pl?Function=getInstrumentList&Item_Id=57325&UL=AV
-
Statistics Canada. (2025a). Per capita sales of alcoholic beverages by liquor authorities and other retail outlets, by value, volume, and absolute volume. Ottawa, Ont.: Author.
Retrieved from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1010001002
-
Statistics Canada. (2025c). Tax filers and dependants with income by total income, sex and age. Ottawa, Ont.: Author.
Retrieved from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1110000801